Alps Advisors Inc. lifted its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 7.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 73,182 shares of the business services provider's stock after buying an additional 5,246 shares during the period. Alps Advisors Inc. owned approximately 0.14% of Exponent worth $5,932,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in EXPO. Atala Financial Inc acquired a new stake in Exponent in the 4th quarter valued at $25,000. Whipplewood Advisors LLC raised its position in Exponent by 5,333.3% in the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock valued at $26,000 after purchasing an additional 320 shares during the period. Brown Brothers Harriman & Co. purchased a new position in Exponent in the fourth quarter valued at about $50,000. UMB Bank n.a. raised its position in Exponent by 859.1% in the first quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock valued at $51,000 after purchasing an additional 567 shares during the period. Finally, Bessemer Group Inc. raised its position in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after purchasing an additional 346 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Exponent
In other news, VP John Pye sold 2,000 shares of Exponent stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the sale, the vice president directly owned 29,204 shares of the company's stock, valued at approximately $2,228,849.28. The trade was a 6.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. Insiders have sold 6,267 shares of company stock valued at $489,120 over the last three months. 1.60% of the stock is owned by company insiders.
Exponent Price Performance
NASDAQ:EXPO opened at $75.98 on Friday. The business's 50-day moving average is $76.57 and its two-hundred day moving average is $82.24. Exponent, Inc. has a 12 month low of $72.43 and a 12 month high of $115.75. The firm has a market capitalization of $3.86 billion, a PE ratio of 37.06 and a beta of 0.90.
Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a return on equity of 25.33% and a net margin of 18.87%. The company had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. During the same period last year, the company posted $0.59 earnings per share. The firm's revenue was up .2% compared to the same quarter last year. Equities analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.58%. The ex-dividend date was Friday, June 6th. Exponent's dividend payout ratio (DPR) is presently 58.54%.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
